Big news in the fight against drug-resistant #malaria:
Eyam Health and @MedsforMalaria are co-developing a long-acting, AI-designed prevention shot—powered by Gemini—for <$1/dose.
https://t.co/FOLOqlOgNb
@RyanM_Thomas
Mpox is surging again! At Eyam, we’re combating the outbreak with our AI-driven Jennerator platform and self-amplifying vaccines. Our goal? Rapid, effective, and accessible solutions for all .
👉 https://t.co/dh84QZ3gEL
#Mpox#Vaccines#Biotech#PandemicPreparedness#Innovation
Eyam announces the appointment of Wolfgang Koester to the Board, one of the “100 Most Influential People in Finance”. CEO, Ryan Thomas, said, “Wolfgang brings a proven track record of global business development at a time when Eyam is ramping up its partnering relationships."
SARS-CoV-2 in Deer: A Cause for Concern?
Researchers at Ohio State University have uncovered fascinating insights into the presence of SARS-CoV-2 in white-tailed deer. (1/5)
Despite a decrease in detections by the CDC and USDA APHIS, the persistence of divergent strains in deer, such as the Alpha variant, poses a new challenge. Understanding these dynamics is crucial to our ongoing battle against the virus. (4/5)
Dive into our latest newsletter with CEO @RyanM_Thomas on pandemic preparedness and the rise of Eris (EG.5). Explore insights into EG.5, its challenges, and the scientific frontlines of our ongoing battle. #PandemicPreparedness#ErisEG5#COVID19
https://t.co/JlOkHLxKdh
As winter approaches, COVID-19 cases are on the rise in the Northern Hemisphere, raising alarms at the WHO. Dr. Maria Van Kerkhove, WHO's technical lead on COVID-19, has urged countries to strengthen surveillance and reporting. (1/4)
We're also keeping a close eye on the highly mutated variant BA.2.86, a new twist in the pandemic.
As we move forward, it's vital to remember that the virus is still evolving, and governments must remain vigilant. (3/4)
Find us next week in-person at the @iambiotech BIO International Convention. As the largest gathering of the global #biotech community, we look forward to meeting with potential new partners. More info here: https://t.co/AUuDKmCh4e or meet with us: [email protected].
We are attending the @iambiotech International Convention in Boston on June 5-8. To meet with Eyam CEO Ryan M. Thomas and Director of Business Development Pamela Lincez, book a 1on1 spot here: [email protected].
https://t.co/UP2KhR1pwI
#standupforscience#bio2023
In collaboration with @mitacscanada, Eyam is founding a new #AI research facility for our #jennerator#bioinformatics platform. We will continue to leverage AI to anticipate new threats and reduce the time to design protective vaccines for both humans and animals.
Eyam CEO Ryan M. Thomas reflects on the importance of #animalvaccines in preventing the spread of #zoonoticdiseases - and how Eyam's latest platform can be used to develop #vaccines for a wide range of #animalspecies. Read the article: https://t.co/lN3aQNILZT